Statin may help fight HIV
February 17th, 2011 - 3:01 pm ICT by ANIWashington, Feb 17 (ANI): Scientists have found that statin may slow down the progression of HIV infection.
In a recent multicenter clinical trial of atorvastatin, a type of cholesterol-lowering drug, the researchers found that although the drug did not inhibit plasma HIV RNA levels, it did inhibit expression of cellular markers of immune activation and inflammation in patients with HIV infection.
Since immune activation and inflammation are associated with progression of HIV infection, the implication is that the statin may inhibit disease progression and help in the infection’s management.
The study, led by Anuradha Ganesan, at the Uniformed Services University of the Health Sciences in Bethesda, Md., randomized 22 HIV-1-infected patients not on antiretroviral therapy and with cholesterol levels lower than those requiring statin therapy in a double-blind protocol of high-dose drug or placebo for eight weeks.
After a four-to-six-week washout phase, each group was switched to the other treatment for another eight weeks.
The primary objective was to study the effect of atorvastatin on plasma HIV-1 RNA levels, as previous studies had shown conflicting results.
The effect on cellular markers of immune activation was a secondary objective. HIV-1 RNA levels were not significantly affected by the drug, but levels of such immune activation markers as CD38 and HLA-DR on CD4 and CD8 T cells were reduced.
The researchers noted that their findings with atorvastatin suggest that understanding the mechanism by which statins affect immune markers may identify new approaches for the management of HIV infection.
The study was published in The Journal of Infectious Diseases. (ANI)
- Cholesterol-lowering statins 'kill bacteria' - Nov 18, 2010
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- New genetic strategy makes T-cells resistant to HIV infection - Jan 27, 2011
- Statins of 'no use for general pediatric lupus population' - Nov 08, 2010
- 'Statins prevent cancer in heart transplant patients' - May 20, 2012
- How HIV infection kills T cells - Nov 25, 2010
- Statins 'slow multiple sclerosis progression' - Apr 15, 2010
- How some people control HIV infection naturally - Nov 05, 2010
- Anti cholesterol drug causes depression: Indian scientists - Jun 23, 2010
- How HIV reactivates after entering a dormant state - Feb 27, 2011
- Protein that contributes to ulcerative colitis revealed - Apr 02, 2011
- Statin can prevent strokes, besides lowering lipids - Jan 05, 2012
- Patients with HIV infection at greater risk of developing heart failure - Apr 26, 2011
- Ranbaxy approved to make first generic version of Lipitor - Dec 01, 2011
- Promising new way to lower cholesterol production - Mar 03, 2011
Tags: atorvastatin, bethesda md, cd4 and cd8, cd8 t cells, cholesterol levels, cholesterol lowering drug, disease progression, ganesan, health sciences, hiv infection, hiv rna levels, hla dr, immune activation, immune markers, infectious diseases, journal of infectious diseases, plasma hiv rna, secondary objective, statin therapy, uniformed services university